PLACE OF TICAGRELOR IN THE NEW RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME

This article presents the main results of large clinical studies that explored the efficacy and safety of antiplatelet agent, P2Y12 inhibitor, ticagrelor. The PLATO, ATLANTIC and PAGASUS-TIMI-54 studies' results formed the basis for inclusion of ticagrelor in the clinical recommendations for th...

Full description

Bibliographic Details
Main Author: A. D. Ehrlich
Format: Article
Language:Russian
Published: «REMEDIUM GROUP» Ltd. 2015-12-01
Series:Атеротромбоз
Subjects:
Online Access:https://www.aterotromboz.ru/jour/article/view/49